Capmatinib usage and dosage

Capmatinib is a kinase inhibitor that targets c-Met receptor tyrosine kinase and is used to treat Met exon 14 skipped non-small cell lung cancer.

The recommended dose of capmatinib is 400 mg taken orally twice daily with or without food. Swallow the tablet whole; Do not break, crush, or chew the tablet. If the patient misses a dose or vomits a dose, instruct the patient not to make up the dose but to take the next dose at the scheduled time. Follow all directions on your prescription label, and read any medication guides or inserts. Your doctor may occasionally change your dose. Take the medicine strictly as directed. Patients need frequent blood tests to check liver function. Do not change the dose or stop taking this medicine without your doctor's advice. If a patient vomits shortly after taking capmatinib, do not take another dose until the next scheduled dose. Store tablets in their original container with a hygroscopic preservative in the packet or jar. Store tablets at room temperature, away from moisture and heat.

Capmatinib can make sunburn more likely if patients avoid the sun or tanning beds, wear protective clothing and use sunscreen (SPF 30 or higher) when outdoors. Sometimes it is unsafe to use certain drugs together. Some drugs can affect the blood levels of other drugs you take, which may increase side effects or make the drugs less effective. Other drugs may affect capmatinib, including prescription and over-the-counter medicines, vitamins, and herbal products. There are generic drugs that are officially on the market in Laos, and each box costs about 3 about 3,000. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.